AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Arrowhead PharmaceuticalsEmergent BiosolutionsGlobal Blood TherapeuticsPTC TherapeuticsFibroGen
SymbolNASDAQ:ARWRNYSE:EBSNASDAQ:GBTNASDAQ:PTCTNASDAQ:FGEN
Price Information
Current Price$32.77$89.30$68.81$50.95$33.65
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.61.41.61.31.7
Analysis Score4.42.44.43.34.3
Community Score2.52.73.02.52.5
Dividend Score0.00.00.00.00.0
Ownership Score1.01.00.00.01.0
Earnings & Valuation Score0.00.60.60.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$62.00$83.86$105.13$62.83$57.60
% Upside from Price Target89.20% upside-6.10% downside52.79% upside23.32% upside71.17% upside
Trade Information
Market Cap$3.28 billion$4.38 billion$4.26 billion$3.19 billion$3.00 billion
Beta1.761.271.91.451.48
Average Volume1,572,434485,040933,688869,218680,658
Sales & Book Value
Annual Revenue$168.80 million$1.11 billion$2.11 million$306.98 million$256.58 million
Price / Sales19.764.231,987.3410.4411.69
Cashflow$0.79 per share$5.51 per shareN/AN/AN/A
Price / Cash41.6016.20N/AN/AN/A
Book Value$2.57 per share$21.08 per share$9.61 per share$9.64 per share$6.14 per share
Price / Book12.754.247.165.295.48
Profitability
Net Income$67.97 million$54.50 million$-266,770,000.00$-251,580,000.00$-76,970,000.00
EPS$0.69$2.91($4.71)($3.45)($0.89)
Trailing P/E Ratio364.1568.69N/AN/AN/A
Forward P/E RatioN/A26.66N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins6.86%6.15%N/A-90.83%-42.75%
Return on Equity (ROE)2.61%14.58%-48.56%-46.42%-19.32%
Return on Assets (ROA)2.08%6.59%-39.45%-17.31%-12.59%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.03%0.71%0.30%0.56%0.07%
Current Ratio5.90%3.03%9.07%3.18%11.14%
Quick Ratio5.90%1.83%8.83%3.09%11.01%
Ownership Information
Institutional Ownership Percentage64.26%85.61%N/AN/A71.66%
Insider Ownership Percentage4.00%14.10%4.20%7.00%7.83%
Miscellaneous
Employees1161,834171511461
Shares Outstanding101.77 million52.43 million60.94 million62.88 million89.11 million
Next Earnings Date8/3/2020 (Estimated)8/6/2020 (Estimated)8/5/2020 (Estimated)8/4/2020 (Estimated)8/13/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.